Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 63 | ECE2019 | Next issue

21st European Congress of Endocrinology

Lyon, France
18 May 2019 - 21 May 2019

Card image cap
18-21 May 2019, Lyon, France

Poster Presentations

Calcium and Bone 2

Previous section
Adrenal and Neuroendocrine Tumours 2
Table of contents
Next section
Diabetes, Obesity and Metabolism 2

ea0063p467 | Calcium and Bone 2

Discovery of a novel NOTCH2 mutation causing Hajdu Cheney Syndrome in a kindred with remarkable phenotypic diversity

ea0063p468 | Calcium and Bone 2

Discovery of a novel CASR mutation causing Familial Hypocalciuric Hypercalcemia in a Greek family

ea0063p469 | Calcium and Bone 2

A case of apparently sporadic primary hyperparathyroidism carrying a germline mutation of CDC73 gene

ea0063p470 | Calcium and Bone 2

Successful management of tertiary hyperparathyroidism associated with hypophosphataemic rickets in an adult

ea0063p471 | Calcium and Bone 2

Parathyroid hormone (PTH) levels are not associated with cancer in patients with primary hyperparathyroidism

ea0063p472 | Calcium and Bone 2

Osteoporosis induced after sleeve gastrectomy in a patient affected of mild asymptomatic primary hyperparathyroidism

ea0063p473 | Calcium and Bone 2

High prevalence of severe vitamin D deficiency in Egyptian females

ea0063p474 | Calcium and Bone 2

Hypophosphatemia in osteoporotic patients referred to a single third level centre: prevalence, clinical features and diagnostic challenges

ea0063p475 | Calcium and Bone 2

McCune-Albright syndrome: report of two cases

ea0063p476 | Calcium and Bone 2

Pineal chordoid meningioma in patient with familial hypocalciuric hypercalcemia, a combination of two rare conditions: Report of a clinical case

ea0063p477 | Calcium and Bone 2

Hypercalcemic crisis of unknown origin: A case report

ea0063p478 | Calcium and Bone 2

Trabecular bone score - a more sensible indicator in predicting negative change than bone mass density?

ea0063p479 | Calcium and Bone 2

Relationship between serum levels of 25-OH vitamin D and parameters of bone mineralization (BMD) and bone quality (TBS) in clinical practice

ea0063p480 | Calcium and Bone 2

Seasonal variation of osteoporotic hip fracture admitted in trauma centers in Bucharest

ea0063p481 | Calcium and Bone 2

Calcitonin response to calcium infusion test in patients with primary hyperparathyroidism

ea0063p482 | Calcium and Bone 2

Effect of hyperparathyroidism on coagulation: an analysis by modified rotation thromboelastogram (ROTEM)

ea0063p483 | Calcium and Bone 2

Parathyroid hormone excess due to denosumab application and concomitant parathyroid adenoma with an atypical scintigraphic pattern- a case report

ea0063p484 | Calcium and Bone 2

Bone mineral density and 10-year probability of fractures in type 2 diabetic patients with different vitamin D status

ea0063p485 | Calcium and Bone 2

Life threatening ‘hypocalcaemia’ secondary to proton pump inhibitor induced ‘functional hypoparathyroidism’

ea0063p486 | Calcium and Bone 2

Dynamic thiol/disulfide homeostasis and oxidant status in patients with hypoparathyroidism

ea0063p487 | Calcium and Bone 2

Hypercalcaemia: hypervitaminosis D or not ?

ea0063p488 | Calcium and Bone 2

Primary hyperparathyroidism with ectopic mediastinal adenoma complicated with brown tumors

ea0063p489 | Calcium and Bone 2

Pregnancy, pancreatitis and hypoglycemia: Difficult management options in a case with MEN-1

ea0063p490 | Calcium and Bone 2

Hyperparathyroidism – jaw tumor syndrome – differential diagnostic traps

ea0063p491 | Calcium and Bone 2

Rickets in a patient with melnick needles syndrome

ea0063p492 | Calcium and Bone 2

Hyperparathyroidism in patients with X-linked hypophosphatemia

ea0063p493 | Calcium and Bone 2

Hypocalcemic cardiomyopathy: a reversible entity?

ea0063p494 | Calcium and Bone 2

Multiglandular parathyroid disease in patients with primary hyperparathyroidism and inconclusive conventional imaging

ea0063p495 | Calcium and Bone 2

Acute pancreatitis, caused by parathyroid gland adenoma: A case report

ea0063p496 | Calcium and Bone 2

A new and effective treatment option for challenging chronic hypoparathyroidism cases: Alternate-day dosing regimen

ea0063p497 | Calcium and Bone 2

Reversible heart disease in iatrogenic hypoparathyroidism

ea0063p498 | Calcium and Bone 2

Bilateral femoral fractures in a pacient with primary hyperparathyroidism: A case report

ea0063p499 | Calcium and Bone 2

Uncommon cutaneous manifestation of primary hyperparathyroidism

ea0063p500 | Calcium and Bone 2

Body mass index is a biomarker of resistance to active vitamin D but not to calcium supplementation, in patients with hypoparathyroidism

ea0063p501 | Calcium and Bone 2

A man with maxillary swelling and tertiary hyperparathyroidism

ea0063p502 | Calcium and Bone 2

Evaluation of bone metabolism in women on aromatase-inhibitors before and after antiresorptive treatment

ea0063p503 | Calcium and Bone 2

Discordance in biochemistry and ultrasonography: Nonsecretory parathyroid adenoma

ea0063p504 | Calcium and Bone 2

Effect of zoledronic acid on trabecular bone score and other markers of bone health in heart transplanted patients

ea0063p505 | Calcium and Bone 2

Impact of three doses of vitamin D on serum 25(OH)D parathyroid hormone in overweight and obese schoolchildren: A single blind randomized clinical trial

ea0063p506 | Calcium and Bone 2

The relation between circulating levels of vitamin D and parathyroid hormone in children and adolescent with overweight or obesity: quest for a threshold

ea0063p507 | Calcium and Bone 2

Fahr syndrome revealing primary hypoparathyroidism: About two cases

ea0063p508 | Calcium and Bone 2

Features of fractures in patients with types 2 diabetes mellitus

ea0063p509 | Calcium and Bone 2

Association between 25 hydroxyvitamin D levels and insulin resistance in a cohort of obese subjects

ea0063p510 | Calcium and Bone 2

Vitamin D repletion in chronic kidney disease patients with secondary hyperparathyroidism

ea0063p511 | Calcium and Bone 2

Gitelman’s syndrome with concomitant primary hyperparathyroidism – case report

ea0063p512 | Calcium and Bone 2

Primary hyperparathyroidism: diagnosis and management

ea0063p513 | Calcium and Bone 2

Clinical-biological presentation hyperparathyroidism primary function of vitamin D status

ea0063p514 | Calcium and Bone 2

Vitamin D insufficiency and hyperparathyroidism, general health and quality of life – a cross sectional study

ea0063p515 | Calcium and Bone 2

Denosumab, alendronate and zoledronate failure to suppress bone resorption markers in a woman affected by severe osteoporosis and subclinical hypercortisolism due to an adrenal adenoma: A case report

ea0063p516 | Calcium and Bone 2

Immobilization induced hypercalcemia

ea0063p517 | Calcium and Bone 2

Denosumab in clinical practice: efficacy, complications and adherence

ea0063p518 | Calcium and Bone 2

Transition of denosumab to primary care is enhanced by use of a transfer pack

ea0063p519 | Calcium and Bone 2

Fahr’s syndrome secondary to hypoparathyroidism: about 11 cases

ea0063p520 | Calcium and Bone 2

Vegan diet: a true danger in paediatrics

ea0063p521 | Calcium and Bone 2

A rare case of cushing disease and hypophosphatasia

ea0063p522 | Calcium and Bone 2

The effect of teriparatide on bone mineral density in a woman with severe lactation-related osteoporosis and multiple vertebral fractures

ea0063p523 | Calcium and Bone 2

Relapse of primary hyperparathyroidism concurrent with a plasma cell proliferative disorder: report of a case

ea0063p524 | Calcium and Bone 2

Diagnosis and treatment of an Argentine patient with severe primary hypoparathyroidism and 22q11.2 deletion syndrome

ea0063p525 | Calcium and Bone 2

The association between magnesium oxide and fracture- A nationwide population-based retrospective cohort study

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more